FDA NDC Directory · JSON-LD · Markdown

duloxetine

NDC 49252-009 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerInventia Healthcare Limited.
Marketing categoryAbbreviated NDA (generic) · App ANDA202336
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (60 mg/1)
Marketing started20151205
Package count5

External sources

Source: openFDA. Public-domain (CC0).